Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys

被引:138
|
作者
Moran, TH [1 ]
Smedh, U [1 ]
Kinzig, KP [1 ]
Scott, KA [1 ]
Knipp, S [1 ]
Ladenheim, EE [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA
关键词
satiety; meal patterns; gut peptides;
D O I
10.1152/ajpregu.00535.2004
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Peptide YY3-36 [PYY(3-36)], a gastrointestinal peptide that is released into the circulation in response to ingesting a meal, has recently been suggested to play a role in controlling food intake. PYY(3-36) has been reported to inhibit food intake following peripheral administration in rodents and in human subjects. To more fully characterize the potential feeding actions of PYY(3-36), we examined the ability of a dose range of PYY(3-36) (0.3-3.0 nmol/kg) to affect liquid gastric emptying and daily 6-h food intake in male rhesus monkeys. Intramuscular PYY(3-36) produced a dose-related inhibition of saline gastric emptying that was maximal at a dose of 3 nmol/kg. Intramuscular PYY(3-36) administered before daily 6-h food access produced significant feeding reductions at doses of 1 and 3 nmol/kg. Analyses of the patterns of food intake across the 6-h period of food access revealed that PYY(3-36) increased the latency to the first meal and reduced average meal size without altering meal number. Although single doses of PYY(3-36) reduced intake, a suppressive effect on food intake was not sustained over multiple administrations across successive days. Together, these data suggest that PYY(3-36) has the ability to reduce food intake in acute test situations in nonhuman primates. Whether this is a physiological action of the endogenous peptide remains to be determined.
引用
收藏
页码:R384 / R388
页数:5
相关论文
共 47 条
  • [41] Differential Acylated Ghrelin, Peptide YY3-36, Appetite, and Food Intake Responses to Equivalent Energy Deficits Created by Exercise and Food Restriction
    King, James A.
    Wasse, Lucy K.
    Ewens, Joshua
    Crystallis, Kathrina
    Emmanuel, Julian
    Batterham, Rachel L.
    Stensel, David J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04): : 1114 - 1121
  • [42] Peripheral exendin-4 and peptide YY3-36 synergistically reduce food intake through different mechanisms in mice
    Talsania, T
    Anini, Y
    Siu, S
    Drucker, DJ
    Brubaker, PL
    ENDOCRINOLOGY, 2005, 146 (09) : 3748 - 3756
  • [43] Co-administration of SR141716 with peptide YY3-36 or oxyntomodulin has additive effects on food intake in mice
    White, N. E.
    Dhillo, W. S.
    Liu, Y. -L.
    Small, C. J.
    Kennett, G. A.
    Gardiner, J. V.
    Ghatei, M. A.
    Bloom, S. R.
    DIABETES OBESITY & METABOLISM, 2008, 10 (02): : 167 - 170
  • [44] Effects of Exendin-4 Alone and With Peptide YY3-36 on Food Intake and Body Weight in Diet-Induced Obese Rats
    Reidelberger, Roger D.
    Haver, Alvin C.
    Apenteng, Bettye A.
    Anders, Krista L.
    Steenson, Sharalyn M.
    OBESITY, 2011, 19 (01) : 121 - 127
  • [45] The inhibitory effects of peripheral administration of peptide YY3-36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway
    Abbott, CR
    Monteiro, M
    Small, CJ
    Sajedi, A
    Smith, KL
    Parkinson, JRC
    Ghatei, MA
    Bloom, SR
    BRAIN RESEARCH, 2005, 1044 (01) : 127 - 131
  • [46] JTT-130, a Novel Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein, Suppresses Food Intake and Gastric Emptying with the Elevation of Plasma Peptide YY and Glucagon-Like Peptide-1 in a Dietary Fat-Dependent Manner
    Hata, Takahiro
    Mera, Yasuko
    Ishii, Yukihito
    Tadaki, Hironobu
    Tomimoto, Daisuke
    Kuroki, Yukiharu
    Kawai, Takashi
    Ohta, Takeshi
    Kakutani, Makoto
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 336 (03): : 850 - 856
  • [47] JTT-130, A Novel Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein, Suppresses Food Intake and Gastric Emptying with the Elevation of Plasma Peptide YY and Glucagon-Like Peptide-1 in a Dietary Fat-Dependent Manner (vol 336, pg 850, 2011)
    Hata, T.
    Mera, Y.
    Ishii, Y.
    Tadaki, H.
    Tomimoto, D.
    Kuroki, Y.
    Ota, T.
    Kawai, T.
    Kakutani, M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 337 (01): : 321 - 322